Clinical Trial Update: The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Mild Headache in People Who Experience Migraines [Phase 2]

View source ↗

Summary

This update reports the completed Phase 2 trial evaluating nasal carbon dioxide as a treatment for mild headache in people with migraines.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Nasal carbon dioxide (carbon dioxide)

Snippet

Sponsor: Capnia, Inc. | Conditions: Migraine | Phase 2 | Status: COMPLETED